Research Paper Volume 15, Issue 21 pp 12275—12295
Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma
Figure 1. The landscape of m5C RNA methylation regulators in glioma. (A, B) Vioplots visualized the differentially expressed m5C regulators between LGG and GBM in TCGA (A) and CGGA (B). (blue represents LGG and red represents GBM). (C, D) Vioplots visualized the differentially expressed m5C regulators with IDH status in TCGA (C) and CGGA (D). (blue represents wild type and red represents mutation type).